Upgrade to SI Premium - Free Trial

Pfizer (PFE) Announces Positive Phase 2 Data in Alopecia Areata at 2018 EADV Congress

September 17, 2018 5:50 AM
Pfizer Inc. (NYSE: PFE) today announced results from its Phase 2a study of PF-06651600, an oral Janus kinase (JAK) 3 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA Management Comments

Next Articles